Clinical trials: Survival Status at Day 30 After the Last Intake
Survival Status at Day 30 After the Last Intake
Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)
The goal of this retrospective observational study is to collect only status survival data 30 days after the last dose of treatment of patients included in the initial protocol WYETH 3074A1-4448 / B1811030.
- Trial name
- NCT01840319
- Where
- 21 sites in France
- Volunteers
- 156 people
- Sponsor
- Pfizer